Sezione di Chirurgia Protesica ad Indirizzo Robotico - Unità di Traumatologia dello Sport, U. O Ortopedia e Traumatologia Fondazione Poliambulanza, Brescia, Italy.
Sezione di Chirurgia Protesica ad Indirizzo Robotico - Unità di Traumatologia dello Sport, U. O Ortopedia e Traumatologia Fondazione Poliambulanza, Brescia, Italy.
Knee. 2020 Oct;27(5):1519-1524. doi: 10.1016/j.knee.2020.08.007. Epub 2020 Aug 27.
Metal hypersensitivity in patients with a total knee arthroplasty (TKA) is a rare condition and a very controversial topic. Despite the lack of data concerning the real effective impact of allergy on TKA failures, most of the manufactures offer the choice of 'non-allergenic' implants both for primary and revision TKA, some of which provide the same designs and surgical techniques as the conventional ones. Only a few studies are available on outcomes on these 'hypersensitivity-friendly' implants and even fewer specifically on allergic patients with a mid- to long-term follow-up.
Between 2007 and 2015, we enrolled 72 patients (57 females, 15 males), who underwent TKA treated with a non-allergenic posterior-stabilized (PS) total knee implant for a declared and proven metal allergy. Patients were followed clinically and radiographically for a mean 10 years of follow-up.
With revision as an endpoint the Kaplan-Meier survival estimate showed a survival rate of 97.2% at five years and 95.1% at 10 years. Significant improvements in range of motion (ROM), Knee Society Scoring (KSS) and Hospital for Special Surgery (HSS) knee scores were registered at final follow-up (P < 0.0001). At final follow-up validated Patient-Reported Outcome Measures (PROMs) showed the following scores: Oxford Knee Score (OKS) 42.1, EQ5D 0.80, EQ VAS 80.1, Forgotten Joint Score 71.2.
This nitrided Ti-6Al-4V titanium alloy fixed-bearing total knee replacement with a highly crosslinked polyethylene-bearing showed interesting results and survival rates in patients with metal allergy at mid- to long-term follow-up.
在全膝关节置换术(TKA)患者中,金属过敏是一种罕见的情况,也是一个非常有争议的话题。尽管缺乏有关过敏对 TKA 失败实际影响的资料,但大多数制造商在初次和翻修 TKA 中都提供“非致敏”植入物的选择,其中一些提供与传统设计和手术技术相同的设计和手术技术。只有少数研究涉及这些“过敏友好”植入物的结果,更少有专门针对具有中至长期随访的过敏患者的研究。
在 2007 年至 2015 年间,我们招募了 72 名患者(57 名女性,15 名男性),他们因明确和已证实的金属过敏而接受了非致敏后稳定型(PS)全膝关节植入物治疗的 TKA。患者接受了平均 10 年的临床和影像学随访。
以翻修为终点,Kaplan-Meier 生存估计显示,五年时的生存率为 97.2%,十年时的生存率为 95.1%。在最终随访时,运动范围(ROM)、膝关节学会评分(KSS)和矫形外科医院(HSS)膝关节评分均显著改善(P<0.0001)。在最终随访时,经过验证的患者报告结局测量(PROMs)显示以下评分:牛津膝关节评分(OKS)42.1、EQ5D 0.80、EQ VAS 80.1、遗忘关节评分 71.2。
在中期至长期随访中,这种氮化钛-6 铝-4 钒钛合金固定轴承全膝关节置换术与高度交联聚乙烯轴承在金属过敏患者中显示出有趣的结果和生存率。